COSM Cosmos Health
- 0.7690
- +0.0115+1.52%
Cosmos Health News
Cosmos Health | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Cosmos Health | 8-K: Current report
Cosmos Health | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Cosmos Health | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Cosmos Health | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Cosmos Health | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Cosmos Health | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Cosmos Health | 8-K: Cosmos Health Regains Compliance With Nasdaq Listing Requirements
Cosmos Health | 8-K/A: Cosmos Health Anticipated Letter from Nasdaq Regarding Form 10-Q and Disclosed About the Appointment of New Independent Registered Auditors(Amendment)
Cosmos Health | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Cosmos Health | 8-K/A: Current report (Amendment)
Cosmos Health | 8-K/A: Current report (Amendment)
Cosmos Health | 8-K: Current report
Cosmos Health | 8-K: Entered Into A Rights Agreement
Cosmos Health | 8-K: Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
Cosmos Health | NT 10-K: Others
Cosmos Health | 8-K: Cosmos Health Receives a Non-Compliance Letter from Nasdaq and Company Defines Policies and Procedures for Related Party Transactions
Cosmos Health | S-3: Registration statement for specified transactions by certain issuers
Cosmos Health | 8-K: Cosmos Health Announces Acquisition of Licenses and Rights to 10 Generic Drugs for €3.2 Million
Cosmos Health | 8-K/A: Cosmos Health Set for Substantial Growth from Acquisitions Completed in 2023 and Entered into a Warrant Exchange Agreement (Amendment)
Analysis
Price Target
No Data
No Data